CERO THERAPEUTICS HOLDINGS, INC. Legal Fees
CERO THERAPEUTICS HOLDINGS, INC. (CERO) reported Legal Fees of $60.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LegalFees · last filed 2025-05-15
- CERO THERAPEUTICS HOLDINGS, INC. legal fees for the quarter ending 2025-03-31 was $60.00K.
- CERO THERAPEUTICS HOLDINGS, INC. legal fees for fiscal 2023 was $150.00K.
| Period end | Legal Fees 2 month | Legal Fees 3 month | Legal Fees 12 month |
|---|---|---|---|
| 2025-03-31 | $60.00K 10-Q · filed 2025-05-15 | ||
| 2024-03-31 | $15.00K 10-Q · filed 2025-05-15 | ||
| 2023-12-31 | $150.00K 10-K · filed 2024-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |